Browse Discover Builder Rankings Pricing

Private market intelligence for investors, founders, and sales teams.

Product

Browse
Discover
List Builder
Rankings
Pricing

Developers

API Reference
API Keys

Company

About
Terms
Privacy
Contact

© 2026 Indexed.vc. All rights reserved.

Tiziana Life Sciences Ltd. Common Shares: Company Profile & Funding | Indexed.vc

Tiziana Life Sciences Ltd. Common Shares

IPO

Home - Tiziana Life Sciences

Headquarters: London
Employees: 11–50
Founded: 2014
Business Model: B2B
Website: tizianalifesciences.com

Total Funding: $13.8M
Last Round: $8.8M Corporate RoundJan 2026
Rounds: 2
Type: Public

About

Tiziana Life Sciences is a biotechnology company developing transformative therapies for neurodegenerative and lung diseases.

LinkedIn X (Twitter)

Tech & App Stack

Tech & App Stack is available on paid plans

Upgrade to Silver or higher to reveal the full technology and app stack for any company.

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Create Free Account

Funding History

Corporate RoundCorporate RoundJan 2026

Jan 2026

Corporate RoundCorporate RoundOct 2024

Oct 2024

IPOOct 2021

Oct 2021

Investors

Sign up to view investors

Create a free account to see which investors have funded this company.

Create Free Account

Similar Companies

Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Drug Discovery

Series D·$1.1B·Feb 2025

Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.

Tianjin, China5001–10000Healthcare, Biotech

Private Equity·$2.3B·Feb 2020

South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...

Chuncheon, South Korea201–500Aesthetics, Biotech

Private Equity·$2.3B·Aug 2021

Global full-service clinical research organization (CRO) and scientific advisory partner for biot...

Sydney, Australia1001–5000Biotech, Healthcare

Growth Equity·$1.9B·Mar 2025

Oscar HealthIPO

Health insurance company using technology to make health care simple, affordable, and accessible.

New York, United States1001–5000Healthcare, Insurance

Series F·$1.9B·Jun 2020

Celerion (H.I.G. Capital)

Global clinical research organization specializing in early-stage clinical trials and bioanalytic...

Lincoln, United States501–1000Biotech, Healthcare

Private Equity·$1.8B·Apr 2026